PCI The Journeys Within
CPHI 2026 – 23/07/2026
Media Pack
News

Current Edition

Volume 18 Issue 2
ramusmedical
news

PCI Continues to Invest According to Market Demand as Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI), full-service...
10 December 2018 news | North America | Regional News
Continue Reading →
Australasia

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commer...
7 December 2018 Australasia | news | North America | Regional News
Continue Reading →
Europe

PCI Pharma Services Celebrates Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back r...
7 December 2018 Europe | news | Regional News
Continue Reading →
news

CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma

In their phase-2 study of tisagenlecleucel (marketed as KYMRIAH®), to be published on-line Dec. 1, 2018 in the New England Journal of Medicine, an international team ...
6 December 2018 news | North America | Regional News
Continue Reading →
Europe

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy di...
6 December 2018 Europe | news | Regional News
Continue Reading →
Europe

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke ...
6 December 2018 Europe | news | Regional News
Continue Reading →
Europe

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

Lyon, France, December 4, 2018 – iDD biotech, a French immuno-oncology company with a large pipeline of preclinical and clinical stage monoclonal antibodies, reports ...
6 December 2018 Europe | news | Regional News
Continue Reading →
Europe

Wearable technology could expand electrophysiology market to $2.6bn by 2028, says GlobalData

Following the news that Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation, She...
6 December 2018 Europe | news | Regional News
Continue Reading →
Europe

First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring

Hannover, Germany, December 03, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the f...
6 December 2018 Europe | news | Regional News
Continue Reading →
news

Polyphor announces positive results from the FDA Type B Guidance meeting on the planned Phase III study for balixafortide

The proposed study is intended to support the global registration of balixafortide. Polyphor expects to enroll the first patient in the second quarter of 2019. Polyph...
6 December 2018 news | North America | Regional News
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte